The finding that phosphoinositide-3-OH kinase δ restrains the antitumour immune response by promoting the action of suppressive immune cells may broaden the applicability of drugs targeting this enzyme to multiple cancers. See Letter p.407
References
Ali, K. et al. Nature 510, 407–411 (2014).
Vanhaesebroeck, B., Guillermet-Guibert, J., Graupera, M. & Bilanges, B. Nature Rev. Mol. Cell Biol. 11, 329–341 (2010).
Hirsch, E., Ciraolo, E., Franco, I., Ghigo, A. & Martini, M. Oncogene http://dx.doi.org/10.1038/onc.2013.265 (2013).
Okkenhaug, K. Annu. Rev. Immunol. 31, 675–704 (2013).
Fruman, D. A. & Cantley, L. C. N. Engl. J. Med. 370, 1061–1062 (2014).
Couzin-Frankel, J. Science 342, 1432–1433 (2013).
Sakaguchi, S., Miyara, M., Costantino, C. M. & Hafler, D. A. Nature Rev. Immunol. 10, 490–500 (2010).
Putz, E. M. et al. PLoS ONE 7, e40852 (2012).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Hirsch, E., Novelli, F. Natural-born killers unleashed. Nature 510, 342–343 (2014). https://doi.org/10.1038/nature13503
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature13503
- Springer Nature Limited